Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
49,625,327
-
Total 13F shares
-
3,780,257
-
Share change
-
-169,992
-
Total reported value
-
$5,972,529
-
Price per share
-
$1.58
-
Number of holders
-
18
-
Value change
-
-$231,570
-
Number of buys
-
9
-
Number of sells
-
10
Institutional Holders of Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) as of Q1 2024
As of 31 Mar 2024 Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,780,257 shares of stock of the company.
Largest 10 holders included Northpond Ventures, LLC, Sands Capital Ventures, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Mariner, LLC, OneDigital Investment Advisors LLC, and STATE STREET CORP.
This table shows 18 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.